Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
about
Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathwayPhase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer.Concurrent chemo-radiotherapy with S-1 as an alternative therapy for elderly Chinese patients with non-metastatic esophageal squamous cancer: evidence based on a systematic review and meta-analysis.A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer.A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer.Pharmacokinetic evaluation of novel oral fluorouracil antitumor drug S-1 in Chinese cancer patients.A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer.Usefulness of alternate-day administration of S-1 and leucovorin in a xenograft mouse model of colorectal cancer: a shorter drug-free interval leads to more efficient antitumor effects.Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer.A randomized phase II study of combination therapy with S-1, oral leucovorin, and oxaliplatin (SOL) and mFOLFOX6 in patients with previously untreated metastatic colorectal cancer.
P2860
Q30834530-7BA5FD2D-CE7B-4331-9E55-6EDFEDA9BB7AQ33428967-EC5A1B30-FB2F-4D0F-A571-AF1C3E607A34Q33914210-3AE31E4E-3962-443C-9AD7-CB3BB4B8B818Q35756882-001FD02C-1FEE-4806-98F1-01DA5DA37423Q36627201-CA0BB97A-7E52-4538-8718-7A1F366F02B3Q37728873-E5500134-5FE3-4BEB-8F45-9BC0907EE59AQ38551668-3A063168-CEC8-43DC-9A50-0052E5E17BC0Q38997864-14B231AC-A8F8-414B-9BAE-A392D940D276Q42288648-EBC212B6-A49C-4986-85B0-9FB937BFB3A4Q53641063-BB77859D-DE2D-477D-9C04-7F2FFF0A337AQ53648255-BADA3EAB-7760-4F41-94E7-D0378573000D
P2860
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
@ast
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
@en
type
label
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
@ast
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
@en
prefLabel
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
@ast
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
@en
P2093
P2860
P356
P1433
P1476
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.
@en
P2093
K Miyashita
K Yamaguchi
T Furuhata
P2860
P304
P356
10.1093/ANNONC/MDP371
P577
2009-10-14T00:00:00Z